Smith & Nephew PLC (SN.)

Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,078.00p

Buy

1,079.00p

arrow-up25.00p (+2.37%)

Prices updated at 15 May 2025, 17:25 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Smith & Nephew PLC designs, manufactures, and markets orthopedic devices and wound-care solutions. Its products include knee replacements, hip implants, nails, fixation devices, arthroscopy tools and others.
FTSE All-Share
arrow-up0.5%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Rupert C Soames OBE
CEO
Mr. Deepak S. Nath
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
17,349
Head office
Hatters Lane
Watford
United Kingdom
WD18 8YE
mobile
+44 1923477100
letter
investorrelations.global@smith-nephew.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Angie Risley
Non-Executive Director, Senior Independent non-executive director
-
Mr. Rupert C Soames OBE
Non-Executive Director, Chairman
-
Mr. Marc E. Owen
Non-Executive Director
-
Mr. Simon Jonathan Lowth
Non-Executive Director
-
Mr. Jeremy Kim Maiden
Non-Executive Director
-
Ms. Joanna Christine Hallas
Non-Executive Director
-
Dr. Katarzyna Mazur-Hofsaess, PhD
Non-Executive Director
-
Ms. Sybella Jane Stanley
Non-Executive Director
-
Dr. John Ma
Non-Executive Director
-
Mr. John Terence Rogers
Executive Director, Chief Financial Officer
-
Mr. Deepak S. Nath
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Principal Global Investors LLC28,887,246
Harris Associates L.P.25,734,884
Vanguard Group Inc25,129,989
Massachusetts Financial Services Company20,894,248
MFS International Intrinsic Value Fd15,178,248

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
01 May 2025Purchase
26 Mar 2025Purchase
19 Dec 2024Purchase
06 Dec 2024Purchase
05 Dec 2024Sale of Option
05 Dec 2024Exercise of Option
11 Nov 2024Purchase
08 Nov 2024D
01 Nov 2024Purchase
23 Sep 2024Purchase
17 Sep 2024Purchase
16 Sep 2024Purchase
16 Sep 2024Purchase
16 Sep 2024Purchase
11 Sep 2024Purchase
06 Aug 2024Purchase
05 Jul 2024Purchase
24 May 2024D
22 May 2024D
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.